Clinical trial
The Efficacy of A Single Dose Clonazepam Compared With the Intermittent Diazepam to Prevent Recurrent Febrile Seizures in Queen Sirikit National Institute of Child Health
NCT04364321 is registered in ClinicalTrials.gov with Queen Sirikit National Institute of Child Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of A Single Dose Clonazepam Compared With the Intermittent Diazepam to Prevent Recurrent Febrile Seizures in Queen Sirikit National Institute of Child Health
- Lead sponsor
- Queen Sirikit National Institute of Child Health
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 13, 2020
- Completion date
- June 30, 2023
- Enrollment
- 74 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent febrile convulsion